K. A. Bedford

841 total citations
22 papers, 672 citations indexed

About

K. A. Bedford is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, K. A. Bedford has authored 22 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 14 papers in Molecular Medicine and 9 papers in Infectious Diseases. Recurrent topics in K. A. Bedford's work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (14 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). K. A. Bedford is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (14 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). K. A. Bedford collaborates with scholars based in United Kingdom and United States. K. A. Bedford's co-authors include Robert A. Wise, J. M. Andrews, J. M. Andrews, P.J. Wills, A.P. Gillett, Tom S. Eaves, T. P. Rollason, M Logan, Alasdair MacGowan and Robert I. Wise and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Journal of Pharmacy and Pharmacology.

In The Last Decade

K. A. Bedford

21 papers receiving 485 citations

Peers

K. A. Bedford

PHARM

EPIDE

L. O. White United Kingdom

R. E. Buck United States

E. Schrinner Germany

A.P. Gillett United Kingdom

P. Acred United Kingdom

F. Faurisson France

T. A. Pursiano United States

N. Klesel Germany

W. Cullmann Germany

J. A. Faiella United States

L. O. White United Kingdom

K. A. Bedford

426 ×1.0

PHARM

217 ×0.7

209 ×1.2

EPIDE

100 ×0.9

94 ×1.0

Citations per year, relative to K. A. Bedford K. A. Bedford (= 1×) peers L. O. White

Countries citing papers authored by K. A. Bedford

Since Specialization

Citations

This map shows the geographic impact of K. A. Bedford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. A. Bedford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. A. Bedford more than expected).

Fields of papers citing papers by K. A. Bedford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. A. Bedford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. A. Bedford. The network helps show where K. A. Bedford may publish in the future.

Co-authorship network of co-authors of K. A. Bedford

This figure shows the co-authorship network connecting the top 25 collaborators of K. A. Bedford. A scholar is included among the top collaborators of K. A. Bedford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. A. Bedford. K. A. Bedford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bedford, K. A., et al.. (2001). Pharmacokinetics of Once-a-Day Netilmicin (4.5 mg/kg) in Neonates. Journal of Chemotherapy. 13(3). 270–276. 9 indexed citations

Bedford, K. A., et al.. (1996). Pharmacokinetics of once-a-day netilmicin (6 mg/kg) in neonates. Journal of Antimicrobial Chemotherapy. 38(3). 499–505. 17 indexed citations

MacGowan, Alasdair, et al.. (1995). The comparative inhibitory and bactericidal activities of meropenem and imipenem against Acinetobacter spp. and Enterobacteriaceae resistant to second generation cephalosporins. Journal of Antimicrobial Chemotherapy. 35(2). 333–337. 10 indexed citations

MacGowan, Alasdair, K. A. Bedford, N. M. Brown, et al.. (1994). The pharmacokinetics of once daily gentamicin in neutropenic adults with haematological malignancy. Journal of Antimicrobial Chemotherapy. 34(5). 809–812. 16 indexed citations

Holt, H. A., L. O. White, K. A. Bedford, et al.. (1994). An evaluation of three new immunoassays for determination of serum gentamicin concentrations. Journal of Antimicrobial Chemotherapy. 34(5). 747–754. 3 indexed citations

Bedford, K. A., et al.. (1984). The evaluation of an automatic system for filling liquids into hard gelatin capsules. Journal of Pharmacy and Pharmacology. 36(2). 119–121. 8 indexed citations

Wise, Robert A., J. M. Andrews, & K. A. Bedford. (1981). Cefoperazone and cefotiam—two new cephalosporins: an in-vitro comparison. Journal of Antimicrobial Chemotherapy. 7(4). 343–352. 8 indexed citations

Wise, Robert A., P.J. Wills, & K. A. Bedford. (1981). Epimers of moxalactam: in vitro comparison of activity and stability. Antimicrobial Agents and Chemotherapy. 20(1). 30–32. 19 indexed citations

Wise, Robert A., J. M. Andrews, & K. A. Bedford. (1980). UK31214, a new aminoglycoside and derivative of kanamycin B. Antimicrobial Agents and Chemotherapy. 17(3). 298–301. 1 indexed citations

10.

Wise, Robert A., P.J. Wills, J. M. Andrews, & K. A. Bedford. (1980). Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins. Antimicrobial Agents and Chemotherapy. 17(1). 84–86. 79 indexed citations

11.

Wise, Robert A., A.P. Gillett, J. M. Andrews, & K. A. Bedford. (1980). Ro 13–9904: A cephalosporin with a high degree of activity and broad antibacterial activity: an in vitro comparative study. Journal of Antimicrobial Chemotherapy. 6(5). 595–600. 32 indexed citations

12.

Wise, Robert A., J. M. Andrews, & K. A. Bedford. (1980). Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds. Antimicrobial Agents and Chemotherapy. 17(5). 884–889. 58 indexed citations

13.

Wise, Robert A., J. M. Andrews, & K. A. Bedford. (1979). LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics. Antimicrobial Agents and Chemotherapy. 16(3). 341–345. 63 indexed citations

14.

Wise, Robert A., J. M. Andrews, & K. A. Bedford. (1978). In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin. Antimicrobial Agents and Chemotherapy. 13(3). 389–393. 86 indexed citations

15.

Wise, Robert A., A.P. Gillett, J. M. Andrews, & K. A. Bedford. (1978). Activity of Azlocillin and Mezlocillin Against Gram-Negative Organisms: Comparison with Other Penicillins. Antimicrobial Agents and Chemotherapy. 13(4). 559–565. 49 indexed citations

16.

Wise, Robert A., J. M. Andrews, & K. A. Bedford. (1978). Comparison of the In Vitro Activity of Bay k 4999 and Piperacillin, Two New Antipseudomonal Broad-Spectrum Penicillins, with Other β-Lactam Drugs. Antimicrobial Agents and Chemotherapy. 14(4). 549–552. 24 indexed citations

17.

Wise, Robert A., T. P. Rollason, M Logan, J. M. Andrews, & K. A. Bedford. (1978). HR 756, a Highly Active Cephalosporin: Comparison with Cefazolin and Carbenicillin. Antimicrobial Agents and Chemotherapy. 14(6). 807–811. 55 indexed citations

18.

Wise, Robert I., J. M. Andrews, & K. A. Bedford. (1977). The Activity of Four Antimicrobial Agents. Including Three Nitroimidazole Compounds, against <i>Bacteroides</i> sp.. Chemotherapy. 23(1). 19–24. 11 indexed citations

19.

Wise, Robert A., J. M. Andrews, & K. A. Bedford. (1977). Pirbenicillin-a semi-synthetic penicillin with antipseudomonal activity. Journal of Antimicrobial Chemotherapy. 3(2). 175–183. 4 indexed citations

20.

Wise, R., J. M. Andrews, & K. A. Bedford. (1975). The antimicrobial effect of combinations of clindamycin and metronidazole with spectinomycinn. Journal of Antimicrobial Chemotherapy. 1(4). 439–440. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact